Publications

Enhanced cytotoxic CD8+ T cell (CTL) antigen recognition by LCK activation
Zheng, Y, Piper, TL, Courtney, AH, The Journal of Immunology, 2022 May; DOI:10.4049/jimmunol.208.supp.55.14
PMID:
Dynamic susceptibility contrast and diffusion-weighted MRI in posterior fossa pilocytic astrocytoma and medulloblastoma
Kurokawa, R, Umemura, Y, Capizzano, A, Kurokawa, M, Baba, A, Holmes, A, Kim, J, Ota, Y, Srinivasan, A, Moritani, T, J Neuroimaging, 2022 May; DOI:10.1111/jon.12962
PMID: 34997668
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Kryczek, I, Liu, J, Green, M, Chinnaiyan, A, Cieslik, M, Zou, W, The Journal of Immunology, 2022 May; DOI:10.4049/jimmunol.208.supp.61.03
PMID:
Outcomes of Initial Transcorporal Versus Standard Placement of Artificial Urinary Sphincter in Patients With Prior Radiation.
Miller, D, Pekala, K, Zhang, X, Orikogbo, O, Rogers, D, Fuller, TW, Maganty, A, Rusilko, P, Cureus, 2022 May; DOI:10.7759/cureus.25519
PMID: 35800826
Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
Michmerhuizen, NL, Ludwig, ML, Birkeland, AC, Nimmagadda, S, Zhai, J, Wang, J, Jewell, BM, Genouw, D, Remer, L, Kim, D, Foltin, SK, Bhangale, A, Kulkarni, A, Bradford, CR, Swiecicki, PL, Carey, TE, Jiang, H, Brenner, JC, Head Neck, 2022 May; DOI:10.1002/hed.27018
PMID: 35224804
Optimization of Biomarker-Based Prostate Cancer Screening Policies
Barnett, CL, Denton, BT, 2022 Apr; DOI:10.1017/9781108872188.011
PMID:
Relatlimab and nivolumab versus nivolumab in previously untreated metastatic or unresectable melanoma: Overall survival and response rates from RELATIVITY-047 (CA224-047)
Long, GV, Hodi, FS, Lipson, EJ, Schadendorf, D, Ascierto, PA, Matamala, L, Salman, P, Gutiérrez, EC, Rutkowski, P, Gogas, H, Lao, CD, Janoski De Menezes, J, Dalle, S, Arance, AM, Grob, J-J, Keidel, S, Shaikh, A, Sobiesk, AM, Dolfi, S, Tawbi, HA, Journal of Clinical Oncology, 2022 Apr; DOI:10.1200/jco.2022.40.36_suppl.360385
PMID:
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue
van Riet, J, Saha, C, Strepis, N, Brouwer, RWW, Martens-Uzunova, ES, van de Geer, WS, Swagemakers, SMA, Stubbs, A, Halimi, Y, Voogd, S, Tanmoy, AM, Komor, MA, Hoogstrate, Y, Janssen, B, Fijneman, RJA, Niknafs, YS, Chinnaiyan, AM, van IJcken, WFJ, van der Spek, PJ, Jenster, G, Louwen, R, Commun Biol, 2022 Apr; DOI:10.1038/s42003-022-03249-4
PMID: 35396392
Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy
Tsao, PA, Ross, RD, Bohnert, ASB, Mukherjee, B, Caram, MEV, Oncologist, 2022 Apr; DOI:10.1093/oncolo/oyab033
PMID: 35298660
BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcoma.
Maurer, LM, Daley, JD, Mukherjee, E, Venier, RE, Julian, CM, Bailey, NG, Jacobs, MF, Kumar-Sinha, C, Raphael, H, Periyapatna, N, Weiss, K, Janeway, KA, Mody, R, Lucas, PC, McAllister-Lucas, LM, Bailey, KM, Cancer Res Commun, 2022 Apr; DOI:10.1158/2767-9764.crc-21-0047
PMID: 36187937
Effect of computerized decision support on diagnostic accuracy and intra-observer variability in multi-institutional observer performance study for bladder cancer treatment response assessment in CT urography
Sun, D, Meyer, N, Hadjiiski, L, Garje, R, Zakharia, Y, Pomerantz, L, Joshi, M, Alva, A, Chan, HP, Cohan, RH, Caoili, EM, Cha, KH, Kirova-Nedyalkova, G, Davenport, MS, Shankar, PR, Francis, IR, Shampain, K, Barkmeier, D, Woolen, S, Palmbos, PL, Weizer, AZ, Samala, RK, Zhou, C, Matuszak, M, Proc SPIE Medical Imaging, 2022 Apr;
PMID:
Pulmonary artery size on computed tomography is associated with major morbidity after pulmonary lobectomy
Kneuertz, PJ, Yudovich, MS, Amadi, CC, Bashian, E, D'Souza, DM, Abdel-Rasoul, M, Merritt, RE, J Thorac Cardiovasc Surg, 2022 Apr; DOI:10.1016/j.jtcvs.2021.01.124
PMID: 33685731
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report
Matin, SF, Pierorazio, PM, Kleinmann, N, Gore, JL, Shabsigh, A, Hu, B, Chamie, K, Godoy, G, Hubosky, SG, Rivera, M, O'Donnell, M, Quek, M, Raman, JD, Knoedler, JJ, Scherr, D, Weight, C, Weizer, A, Woods, M, Kaimakliotis, H, Smith, AB, Linehan, J, Coleman, J, Humphreys, MR, Pak, R, Lifshitz, D, Verni, M, Klein, I, Konorty, M, Strauss-Ayali, D, Hakim, G, Seltzer, E, Schoenberg, M, Lerner, SP, J Urol, 2022 Apr; DOI:10.1097/JU.0000000000002350
PMID: 34915741
Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
Mark Fendrick, A, Borah, BJ, Burak Ozbay, A, Saoud, L, Limburg, PJ, Prev Med Rep, 2022 Apr; DOI:10.1016/j.pmedr.2022.101701
PMID: 35106276
Out-of-Pocket Costs for Colposcopy Among Commercially Insured Women From 2006 to 2019
Fendrick, AM, Dalton, VK, Tilea, A, Malone, AM, Moniz, MH, Obstetrical & Gynecological Survey, 2022 Apr; DOI:10.1097/01.ogx.0000823956.54119.99
PMID:
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
Thompson, JA, Schneider, BJ, Brahmer, J, Achufusi, A, Armand, P, Berkenstock, MK, Bhatia, S, Budde, LE, Chokshi, S, Davies, M, Elshoury, A, Gesthalter, Y, Hegde, A, Jain, M, Kaffenberger, BH, Lechner, MG, Li, T, Marr, A, McGettigan, S, McPherson, J, Medina, T, Mohindra, NA, Olszanski, AJ, Oluwole, O, Patel, SP, Patil, P, Reddy, S, Ryder, M, Santomasso, B, Shofer, S, Sosman, JA, Wang, Y, Zaha, VG, Lyons, M, Dwyer, M, Hang, L, J Natl Compr Canc Netw, 2022 Apr; DOI:10.6004/jnccn.2022.0020
PMID: 35390769
Fusion of multiple deep convolutional neural networks (DCNNs) for improved segmentation of lung nodules in CT images.
Wang, Y, Zhou, C, Chan, HP, Hadjiiski, L, Chughtai, A, Proc SPIE Medical Imaging, 2022 Apr;
PMID:
A transcriptomic model for homologous recombination deficiency in prostate cancer
Weiner, AB, Liu, Y, McFarlane, M, Bawa, PS, Li, EV, Zhao, X, Li, Z, Hammoud, T, Hazime, M, Karnes, RJ, Davicioni, E, Reichert, ZR, Chinnaiyan, AM, Lotan, TL, Spratt, DE, Schaeffer, EM, Prostate Cancer Prostatic Dis, 2022 Apr; DOI:10.1038/s41391-021-00416-2
PMID: 34226663
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer
Labanca, E, Yang, J, Shepherd, PDA, Wan, X, Starbuck, MW, Guerra, LD, Anselmino, N, Bizzotto, JA, Dong, J, Chinnaiyan, AM, Ravoori, MK, Kundra, V, Broom, BM, Corn, PG, Troncoso, P, Gueron, G, Logothethis, CJ, Navone, NM, Eur Urol Oncol, 2022 Apr; DOI:10.1016/j.euo.2021.10.001
PMID: 34774481
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin.
Talukder, R, Makrakis, D, Diamantopoulos, LN, Carril-Ajuria, L, Castellano, D, De Kouchkovsky, I, Koshkin, VS, Park, JJ, Alva, A, Bilen, MA, Stewart, TF, McKay, RR, Santos, VS, Agarwal, N, Jain, J, Zakharia, Y, Morales-Barrera, R, Devitt, ME, Grant, M, Lythgoe, MP, Pinato, DJ, Nelson, A, Hoimes, CJ, Shreck, E, Gartrell, BA, Sankin, A, Tripathi, A, Zakopoulou, R, Bamias, A, Murgic, J, Fröbe, A, Rodriguez-Vida, A, Drakaki, A, Liu, S, Kumar, V, Lorenzo, GD, Joshi, M, Velho, PI, Buznego, LA, Duran, I, Moses, M, Barata, P, Sonpavde, G, Yu, EY, Wright, JL, Grivas, P, Khaki, AR, Clin Genitourin Cancer, 2022 Apr; DOI:10.1016/j.clgc.2021.12.012
PMID: 35078711
The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity.
Fecher, LA, Bishu, S, Fontana, RJ, Hayek, SS, Schneider, BJ, J Natl Compr Canc Netw, 2022 Apr; DOI:10.6004/jnccn.2022.7011
PMID: 35390763
Post-discharge Opioid Consumption after Minimally Invasive and Open Colectomy: Does Operative Approach Matter?
Vu, J, Cleary, RK, Englesbe, MJ, Brummett, CM, Waljee, JF, Suwanabol, PA, Ann Surg, 2022 Apr; DOI:10.1097/SLA.0000000000004240
PMID: 32657943
Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice.
Verhaegen, ME, Harms, PW, Van Goor, JJ, Arche, J, Patrick, MT, Wilbert, D, Zabawa, H, Grachtchouk, M, Liu, C-J, Hu, K, Kelly, MC, Chen, P, Saunders, TL, Weidinger, S, Syu, L-J, Runge, JS, Gudjonsson, JE, Wong, SY, Brownell, I, Cieslik, M, Udager, AM, Chinnaiyan, AM, Tsoi, LC, Dlugosz, AA, J Clin Invest, 2022 Apr; DOI:10.1172/JCI152069
PMID: 35143422
Pathogenic ATM and BAP1 germline mutations in a case of early-onset, familial sarcomatoid renal cancer.
Bell, HN, Kumar-Sinha, C, Mannan, R, Zakalik, D, Zhang, Y, Mehra, R, Jagtap, D, Dhanasekaran, SM, Vaishampayan, U, Cold Spring Harb Mol Case Stud, 2022 Apr; DOI:10.1101/mcs.a006203
PMID: 35483881
TP53 mutations in head and neck cancer
Nathan, C-A, Khandelwal, AR, Wolf, GT, Rodrigo, JP, Mäkitie, AA, Saba, NF, Forastiere, AA, Bradford, CR, Ferlito, A, Mol Carcinog, 2022 Apr; DOI:10.1002/mc.23385
PMID: 35218075